Raju Prasad, CFO: Crispr Therapeutics CRSP Sell · Filed 03/17

Trade details

Type: Insider sale
Amount: $194,053.46
Shares · price: 4,021 sh · $48.26 a share
Held after: 13,773 sh
Stock: Crispr Therapeutics CRSP
Person: Raju PrasadCFO
Trade date: 26/03/16
Filed: 26/03/17
Days to filing: 1 days

Sold 22.6% of holdings

Share of holding sold: 22.6%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Raju Prasad's recent trades

Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$173.5K
3,708 sh
$173.5K
Filed 03/24
Traded 03/23
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$282.2K
5,848 sh
$282.2K
Filed 03/17
Traded 03/16
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/26
Traded 01/22
Raju PrasadCFO
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/22
Traded 01/22
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$1.1M
18,933 sh
$1.1M
Filed 01/08
Traded 01/06

Raju Prasad, CFO — sold $194.1K of Crispr Therapeutics CRSP · 22.6% of holdings | Whalegun